Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tagliabue, Elda"'
Autor:
Triulzi T; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Di Cosimo S; DRAST, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pienkowski T; Oncology and Breast Diseases Department, Postgraduate Medical Education Center, Warsaw, Poland., Im YH; Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea., Bianchi GV; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., De Cecco L; DRAST, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tseng LM; Taipei-Veterans General Hospital, National Yang-Ming University, Taiwan., Liu MC; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Bermejo B; Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain., Semiglazov V; NN Petrov Research Institute of Oncology, St Petersburg, Russia., Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., de la Haba-Rodriguez J; Hospital Reina Sofia, Córdoba, Spain., Oh DY; Division of Medical Oncology, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Republic of Korea., Poirier B; Centre des Maladies du sein, Hôpital du Saint-Sacrement, CHU de Québec, Canada., Valagussa P; Fondazione Michelangelo, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy.; Fondazione Gianni Bonadonna, Milan, Italy., Tagliabue E; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Jun; Vol. 16 (12), pp. 2355-2366. Date of Electronic Publication: 2021 Dec 17.
Autor:
Lecchi M; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cappelletti V; Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Santis F; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Paolini B; Pathology A Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Monica M; Pathology A Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sangaletti S; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pupa SM; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Iorio MV; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchi G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gennaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fucà G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Nicola M; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Molecular oncology [Mol Oncol] 2021 May; Vol. 15 (5), pp. 1345-1357. Date of Electronic Publication: 2021 Feb 19.
Autor:
Beltrán-Anaya FO; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.; Programa de Doctorado en Ciencias Biomédicas, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico., Romero-Córdoba S; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.; Department of Experimental Oncology and Molecular Medicine, Istituto Nazionale dei Tumori, Milan, Italy., Rebollar-Vega R; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Bautista-Piña V; Instituto de Enfermedades de la Mama FUCAM, Mexico City, Mexico., Dominguez-Reyes C; Instituto de Enfermedades de la Mama FUCAM, Mexico City, Mexico., Villegas-Carlos F; Instituto de Enfermedades de la Mama FUCAM, Mexico City, Mexico., Tenorio-Torres A; Instituto de Enfermedades de la Mama FUCAM, Mexico City, Mexico., Alfaro-Riuz L; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Jiménez-Morales S; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Cedro-Tanda A; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.; Programa de Doctorado en Ciencias Biomédicas, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico., Ríos-Romero M; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Reyes-Grajeda JP; Unidad de Proteómica Médica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Tagliabue E; Department of Experimental Oncology and Molecular Medicine, Istituto Nazionale dei Tumori, Milan, Italy., Iorio MV; Department of Experimental Oncology and Molecular Medicine, Istituto Nazionale dei Tumori, Milan, Italy., Hidalgo-Miranda A; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Publikováno v:
Molecular oncology [Mol Oncol] 2019 Apr; Vol. 13 (4), pp. 909-927. Date of Electronic Publication: 2019 Feb 09.
Autor:
Plantamura I; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: ilaria.plantamura@istitutotumori.mi.it., Casalini P; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: patrizia.casalini@istitutotumori.mi.it., Dugnani E; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: erica.dugnani@istitutotumori.mi.it., Sasso M; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: marianna.sasso@istitutotumori.mi.it., D'Ippolito E; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: elvira.dippolito@istitutotumori.mi.it., Tortoreto M; Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: monica.tortoreto@istitutotumori.mi.it., Cacciatore M; Department of Human Pathology, University of Palermo, Palermo, Italy. Electronic address: matilde.cacciatore@unipa.it., Guarnotta C; Department of Human Pathology, University of Palermo, Palermo, Italy. Electronic address: carla.guarnotta@unipa.it., Ghirelli C; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: cristina.ghirelli@istitutotumori.mi.it., Barajon I; Institute of Human Morphology and Biomedical Sciences 'Città Studi', University of Milan, 20133 Milan, Italy. Electronic address: isabella.barajon@unimi.it., Bianchi F; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: francesca.bianchi@istitutotumori.mi.it., Triulzi T; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: tiziana.triulzi@istitutotumori.mi.it., Agresti R; Division of Surgical Oncology, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy. Electronic address: roberto.agresti@istitutotumori.mi.it., Balsari A; Institute of Human Morphology and Biomedical Sciences 'Città Studi', University of Milan, 20133 Milan, Italy. Electronic address: andrea.balsari@unimi.it., Campiglio M; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: manuela.campiglio@istitutotumori.mi.it., Tripodo C; Department of Human Pathology, University of Palermo, Palermo, Italy. Electronic address: claudio.tripodo@unipa.it., Iorio MV; Start Up Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: marilena.iorio@istitutotumori.mi.it., Tagliabue E; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: elda.tagliabue@istitutotumori.mi.it.
Publikováno v:
Molecular oncology [Mol Oncol] 2014 Jul; Vol. 8 (5), pp. 968-81. Date of Electronic Publication: 2014 Mar 27.
Autor:
Piovan C; Departments of Molecular Virology, Immunology and Human Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA., Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CM
Publikováno v:
Molecular oncology [Mol Oncol] 2012 Aug; Vol. 6 (4), pp. 458-72. Date of Electronic Publication: 2012 Apr 19.
Autor:
Podo F; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. franca.podo@iss.it, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sørlie T, Tagliabue E, Børresen-Dale AL
Publikováno v:
Molecular oncology [Mol Oncol] 2010 Jun; Vol. 4 (3), pp. 209-29. Date of Electronic Publication: 2010 Apr 24.